Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 

Abstract/Editors' Note | Full Text | PDF

FIGURES/TABLES SUMMARY PAGE

PowerPoint slides are available for most Figures at Annals.org

Cost-Effectiveness of Cardiac Resynchronization Therapy in Patients with Symptomatic Heart Failure



View larger version (14K):

[in a new window]
  		Figure 1. Markov model of medical therapy for heart failure.

 


View larger version (19K):

[in a new window]
  		Figure 2. Markov model of cardiac resynchronization therapy (CRT) for heart failure.

 

View this table:

[in a new window]
  		Table 1. Input Data

 

View this table:

[in a new window]
  		Table 2. Potential Cost-Effectiveness of Cardiac Resynchronization Therapy Compared with Medical Therapy

 


View larger version (23K):

[in a new window]
  		Figure 3. Distribution of incremental costs versus incremental effects for cardiac resynchronization therapy versus medical therapy. For the base-case point estimate (white X), incremental costs = $30 252 and incremental effect = 0.282 quality-adjusted life-year (QALY).

 


View larger version (14K):

[in a new window]
  		Appendix Figure. Cost-effectiveness acceptability curve. QALY = quality-adjusted life-year.

 

View this table:

[in a new window]
  		Appendix Table. Characteristics of Respondents

 



 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 2004 by the American College of Physicians.